Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pregnancy anemia study: iron pills under the microscope

NCT ID NCT03725150

Knowledge-focused Sponsor: The Royal Wolverhampton Hospitals NHS Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well pregnant women with iron deficiency anemia tolerate and stick with oral iron therapy. Researchers tracked side effects and checked if iron levels improved using blood tests. The goal was to better understand how to treat this common condition during pregnancy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

120 people

The number who actually took part.

Started

Jun 2018

Finished

Dec 2019

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Anaemic (iron-deficient) pregnant women receiving oral iron replacement therapy.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women (any stage during pregnancy up to 36 weeks) and women in the puerperium (within 6 weeks postdelivery) with anaemia as defined by World Health Organization (WHO) criteria and described in British Society Haematology (BSH)/ British Committee for standards in Haematology (BCSH) guidelines. 1. First trimester \< 110g/l 2. Second and third trimester \< 105g/l 3. Puerperium \< 100g/l * Age: 18-45 years * Agreement to participate in the study with consenting Exclusion Criteria: * Anaemic women presenting at or after 36 weeks as there may be insufficient time to delivery to assess responses to oral iron) * Anaemic women affected by a (major) haemoglobinopathy e.g. B thalassaemia major sickle cell disease * Women with overt clinical signs of sepsis * Allergies to iron * Hyperemesis Gravidarum / persistent vomiting * Women with inflammatory conditions such as Crohns, ulcerative colitis, Systemic lupus erythematosus, Rheumatoid arthritis. * Women with chronic renal failure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anemia, iron-deficiency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anemia, iron-deficiency

Contacts and locations

Locations

  • New Cross Hospital

    Wolverhampton, West Midlands, WV10 0QP, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.